Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Jeffrey SY Huang"'
Autor:
Paul G. Richardson, Aurore Perrot, Jesús San-Miguel, Meral Beksac, Ivan Spicka, Xavier Leleu, Fredrik Schjesvold, Philippe Moreau, Meletios A. Dimopoulos, Jeffrey SY Huang, Jiri Minarik, Michele Cavo, H. Miles Prince, Sandrine Macé, Laure Malinge, Franck Dubin, Mony Morisse, Kenneth C. Anderson
Publikováno v:
Blood. 140:608-610
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fdcb8c78077bf15e28b88ac599a443eb
https://doi.org/10.1182/blood-2022-159710
https://doi.org/10.1182/blood-2022-159710
Autor:
Michel Attal, Meletios A. Dimopoulos, Philippe Moreau, Franck Dubin, Sandrine Macé, Solenn Le-Guennec, Paul G. Richardson, S. Vincent Rajkumar, Michele Cavo, Meral Beksac, Frank Campana, Jiri Minarik, Jesús F. San Miguel, Kenneth C. Anderson, Ivan Spicka, H. Miles Prince, Xavier Leleu, Fredrik Schjesvold, Kathryn P. Corzo, Jeffrey Sy. Huang
Publikováno v:
Journal of Clinical Oncology. 37:8004-8004
8004 Background: The primary objective of this phase 3 trial was to demonstrate progression free survival (PFS) improvement of isatuximab (Isa), a novel anti-CD38 monoclonal antibody, combined with pomalidomide (P)/dexamethasone (d) versus (vs) Pd. M
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::763e1fbcca36e6f6520a6bca55d6381e
https://doi.org/10.1200/jco.2019.37.15_suppl.8004
https://doi.org/10.1200/jco.2019.37.15_suppl.8004